Клинический разбор в общей медицине

1. Всемирная организация здравоохранения. Женщины и здоровье. URL: https://www.who.int/ru/news-room/fact-sheets/detail/women-s-health. Дата обращения: 07.12.2025.

World Health Organization. Women and Health. URL: https://www.who.int/ru/news-room/fact-sheets/detail/women-s-health. Accessed on December 7, 2025 (in Russian).

2. Balta MG, Papathanasiou E, Blix IJ, Van Dyke TE. Host Modulation and Treatment of Periodontal Disease. J Dent Res 2021;100(8):798-809. DOI: 10.1177/0022034521995157

3. O'Dwyer MC, Furgal A, Furst W et al. The Prevalence of Periodontitis Among US Adults with Multimorbidity Using NHANES Data 2011-2014. J Am Board Fam Med 2023;36(2):313-24. DOI: 10.3122/jabfm.2022.220207R1

4. Badran Z, Struillou X, Verner C et al. Periodontitis as a risk factor for systemic disease: Are microparticles the missing link? Med Hypotheses 2015;84(6):555-6. DOI: 10.1016/j.mehy.2015.02.013

5. Pai SI, Matheus HR, Guastaldi FPS. Effects of periodontitis on cancer outcomes in the era of immunotherapy. Lancet Healthy Longev 2023;4(4):e166-e175. DOI: 10.1016/S2666-7568(23)00021-1

6. Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes--systematic review. J Periodontol 2013;84(4 Suppl):S181-94. DOI: 10.1902/jop.2013.134009

7. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim) 2017;11(2):72-80. URL: https://pubmed.ncbi.nlm.nih.gov/28539867/

8. Valentine GC, Perez K, Tsegaye AT et al. Nonsurgical periodontal treatment during pregnancy and rates of preterm birth. AJOG Glob Rep 2023;3(1):100167. DOI: 10.1016/j.xagr.2023.100167

9. Opacic J, Maldonado A, Ramseier CA, Laugisch O. Influence of periodontitis on pregnancy and childbirth. Swiss Dent J 2019;129(7-8):581-9. DOI: 10.61872/sdj-2019-07-08-03.

10. Chanomethaporn A, Chayasadom A, Wara-Aswapati N et al. Association between periodontitis and spontaneous abortion: A case-control study. J Periodontol 2019;90(4):381-90. DOI: 10.1002/JPER.18-0174

11. Uwambaye P, Munyanshongore C, Rulisa S et al. Assessing the association between periodontitis and premature birth: a case-control study. BMC Pregnancy Childbirth 2021;21(1):204. DOI: 10.1186/s12884-021-03700-0

12. Manrique-Corredor EJ, Orozco-Beltran D, Lopez-Pineda A. Maternal periodontitis and preterm birth: Systematic review and meta-analysis. Community Dent Oral Epidemiol 2019;47(3):243-51. DOI: 10.1111/cdoe.12450

13. Shahi A, Khosravi S, Rezvan F et al. Evaluation of the periodontal disease on oral microorganisms during pregnancy: A systematic review and meta-analysis. J Clin Transl Res 2023;9(3):144-52. URL: https://pubmed.ncbi.nlm.nih.gov/37181818/

14. Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol 2020;120:45-84. DOI: 10.1016/bs.apcsb.2019.12.001

15. Borsa L, Dubois M, Sacco G, Lupi L. Analysis the link between periodontal diseases and Alzheimer’s disease: A systematic review. Int J Environ Res Public Health 2021;18(17):9312. DOI: 10.3390/ijerph18179312

16. Polishchuk H, Synowiec A, Zubrzycka N, Kantyka T. Porphyromonas gingivalis: Multiple Tools of an Inflammatory Damage. Mol Oral Microbiol 2025;40(5):159-6. DOI: 10.1111/omi.12496

17. Reyes L, Phillips P, Wolfe B et al. Porphyromonas gingivalis and adverse pregnancy outcome. J Oral Microbiol 2017;10(1):1374153. DOI: 10.1080/20002297.2017.1374153

18. Mei F, Xie M, Huang X et al. Porphyromonas gingivalis and Its Systemic Impact: Current Status. Pathogens 2020;9(11):944. DOI: 10.3390/pathogens9110944

19. Vanterpool SF, Been JV, Houben ML et al. Porphyromonas gingivalis within Placental Villous Mesenchyme and Umbilical Cord Stroma Is Associated with Adverse Pregnancy Outcome. PLoS One 2016;11(1):e0146157. DOI: 10.1371/journal.pone.0146157

20. León R, Silva N, Ovalle A et al. Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol 2007;78(7):1249-55. DOI: 10.1902/jop.2007.060368

21. Chaparro A, Blanlot C, Ramírez V et al. Porphyromonas gingivalis, Treponema denticola and toll-like receptor 2 are associated with hypertensive disorders in placental tissue: a case-control study. J Periodontal Res 2013;48(6):802-9. DOI: 10.1111/jre.12074

22. Savitha JN, Bhavya B, Yadalam U, Khan SF. Detection of Porphyromonas gingivalis in umbilical cord blood of new-born and in subgingival plaque of pregnant participants with periodontal disease and its association with pregnancy outcomes: An observational study. J Indian Soc Periodontol 2022;26(4):365-72. DOI: 10.4103/jisp.jisp_45_21

23. Lin D, Smith MA, Champagne C et al. Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 2003;71(9):5156-62. DOI: 10.1128/IAI.71.9.5156-5162.2003

24. Lin D, Smith MA, Elter J et al. Porphyromonas gingivalis infection in pregnant mice is associated with placental dissemination, an increase in the placental Th1/Th2 cytokine ratio, and fetal growth restriction. Infect Immun 2003;71(9):5163-8. DOI: 10.1128/IAI.71.9.5163-5168.2003

25. Liang S, Ren H, Guo H et al. Periodontal infection with Porphyromonas gingivalis induces preterm birth and lower birth weight in rats. Mol Oral Microbiol 2018;33(4):312-21. DOI: 10.1111/omi.12227

26. Gómez LA, De Avila J, Castillo DM et al. Porphyromonas gingivalis Placental Atopobiosis and Inflammatory Responses in Women With Adverse Pregnancy Outcomes. Front Microbiol 2020;11:591626. DOI: 10.3389/fmicb.2020.591626

27. Araneda-Rojas S, Castillo C, Liempi A et al. Porphyromonas gingivalis Lysate Induces TLR-2/4-Dependent NF-κB Activation and Inflammatory Damage in the Human Placental Barrier. Int J Mol Sci 2025;26(19):9558. DOI: 10.3390/ijms26199558

28. Miyauchi M, Ao M, Furusho H et al. Galectin-3 Plays an Important Role in Preterm Birth Caused by Dental Infection of Porphyromonas gingivalis. Sci Rep 2018;8(1):2867. DOI: 10.1038/s41598-018-21072-y

29. Ao M, Miyauchi M, Furusho H et al. Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in Mice. PLoS One 2015;10(8):e0137249. DOI: 10.1371/journal.pone.0137249

30. Inaba H, Kuboniwa M, Bainbridge B et al Porphyromonas gingivalis invades human trophoblasts and inhibits proliferation by inducing G1 arrest and apoptosis. Cell Microbiol 2009;11(10):1517-32. DOI: 10.1111/j.1462-5822.2009.01344.x

31. Zambirinis CP, Levie E, Nguy S et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med 2015;212(12):2077-94. DOI: 10.1084/jem.20142162

32. Takii R, Kadowaki T, Tsukuba T, Yamamoto K. Inhibition of gingipains prevents Porphyromonas gingivalis-induced preterm birth and fetal death in pregnant mice. Eur J Pharmacol 2018;824:48-56. DOI: 10.1016/j.ejphar.2018.01.028

33. Katz J, Chegini N, Shiverick KT, Lamont RJ. Localization of P. gingivalis in preterm delivery placenta. J Dent Res 2009;88(6):575-8. DOI: 10.1177/0022034509338032

34. Hirohata N, Komine-Aizawa S, Tamura M et al. Porphyromonas gingivalis Suppresses Trophoblast Invasion by Soluble Factors. J Periodontol 2017;88(12):1366-73. DOI: 10.1902/jop.2017.170193

35. Lara B, Loureiro I, Gliosca L et al. Porphyromonas gingivalis outer membrane vesicles shape trophoblast cell metabolism impairing functions associated to adverse pregnancy outcome. J Cell Physiol 2023;238(11):2679-91. DOI: 10.1002/jcp.31138

36. Tanai A, Fukuhara Y, Eguchi T et al. P. gingivalis-Infected Macrophage Extracellular Vesicles Cause Adverse Pregnancy Outcomes. J Dent Res 2025;104(1):54-63. DOI: 10.1177/00220345241285132

37. Tavarna T, Phillips PL, Wu XJ, Reyes L. Fetal growth restriction is a host specific response to infection with an impaired spiral artery remodeling-inducing strain of Porphyromonas gingivalis. Sci Rep 2020;10(1):14606. DOI: 10.1038/s41598-020-71762-9.

38. Kamei-Nagata C, Omori K, Sako H et al. Periodontitis associated with Porphyromonas gingivalis infection is a risk factor for infertility through uterine hypertrophy. Sci Rep 2025;15(1):34964. DOI: 10.1038/s41598-025-18992-x

39. Ye C, Kobayashi H, Katagiri S et al. The relationship between the anti-Porphyromonas gingivalis immunoglobulin G subclass antibody and small for gestational age delivery: a longitudinal study in pregnant Japanese women. Int Dent J 2020;70(4):296-302. DOI: 10.1111/idj.12548

40. Chopra A, Radhakrishnan R, Sharma M. Porphyromonas gingivalis and adverse pregnancy outcomes: a review on its intricate pathogenic mechanisms. Crit Rev Microbiol 2020;46(2):213-36. DOI: 10.1080/1040841X.2020.1747392

41. Cobb CM, Kelly PJ, Williams KB et al. The oral microbiome and adverse pregnancy outcomes. Int J Womens Health 2017;9:551-9. DOI: 10.2147/IJWH.S142730

42. Guan ZW, Xu TQ, Shen S et al. Pathways and Mechanisms of Periodontitis Contributing to Adverse Pregnancy Outcomes. Sichuan Da Xue Xue Bao Yi Xue Ban 2023;54(1):39-48. DOI: 10.12182/20230160501

43. Gorczyca K, Obuchowska A, Kimber-Trojnar Ż et al. Changes in the Gut Microbiome and Pathologies in Pregnancy. Int J Environ Res Public Health 2022;19(16):9961. DOI: 10.3390/ijerph19169961

44. Xie Y, Chen Q, Shan D et al. Unraveling the role of the gut microbiome in pregnancy disorders: insights and implications. Front Cell Infect Microbiol 2025;15:1521754. DOI: 10.3389/fcimb.2025.1521754

45. Takada K, Komine-Aizawa S. Bacterial vaginosis and the gut-vagina axis. Microbiol Spectr 2025;13(9):e0124425. DOI: 10.1128/spectrum.01244-25

46. Gare J, Kanoute A, Meda N et al. Periodontal Conditions and Pathogens Associated with Pre-Eclampsia: A Scoping Review. Int J Environ Res Public Health 2021;18(13):7194. DOI: 10.3390/ijerph18137194

47. Wen X, Fu X, Zhao C et al. The bidirectional relationship between periodontal disease and pregnancy via the interaction of oral microorganisms, hormone and immune response. Front Microbiol 2023;14:1070917. DOI: 10.3389/fmicb.2023.1070917

48. Fischer LA, Demerath E, Bittner-Eddy P, Costalonga M. Placental colonization with periodontal pathogens: the potential missing link. Am J Obstet Gynecol 2019;221(5):383-392.e3. DOI: 10.1016/j.ajog.2019.04.029

49. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-58. DOI: 10.1128/CMR.13.4.547

50. Cetin I, Pileri P, Villa A et al. Pathogenic mechanisms linking periodontal diseases with adverse pregnancy outcomes. Reprod Sci 2012;19(6):633-41. DOI: 10.1177/1933719111432871

51. Groeger S, Jarzina F, Domann E, Meyle J. Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunol 2017;18(1):1. DOI: 10.1186/s12865-016-0185-5

52. Puertas A, Magan-Fernandez A, Blanc V et al. Association of periodontitis with preterm birth and low birth weight: a comprehensive review. J Matern Fetal Neonatal Med 2018;31(5):597-602. DOI: 10.1080/14767058.2017.1293023

53. Wu J, Wu J, Tang B et al. Effects of different periodontal interventions on the risk of adverse pregnancy outcomes in pregnant women: a systematic review and network meta-analysis of randomized controlled trials. Front Public Health 2024;12:1373691. DOI: 10.3389/fpubh.2024.1373691

54. Salama M, Al-Taiar A, McKinney DC et al. The impact of scaling and root planning combined with mouthwash during pregnancy on preterm birth and low birth weight: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2024;24(1):726. DOI: 10.1186/s12884-024-06905-1

55. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Клинические рекомендации Минздрава России. М., 2024. URL: https://cr.minzdrav.gov.ru/preview-cr/637_2

Preeclampsia. Eclampsia. Edema, proteinuria, and hypertensive disorders during pregnancy, labor, and the postpartum period. Clinical guidelines of the Ministry of Health of Russia. Moscow, 2024. URL: https://cr.minzdrav.gov.ru/preview-cr/637_2 (in Russian).

56. Ali M, Ahmed M, Memon M et al. Preeclampsia: A comprehensive review. Clin Chim Acta 2024;563:119922. DOI: 10.1016/j.cca.2024.119922

57. Савельева Г.М., Шалина Р.И., Сичинава Л.Г. и др. Акушерство: учебник. М.: ГЭОТАР-Медиа, 2020. URL: https://www.geotar.ru/lots/NF0008921.html

Savelyeva G.M., Shalina R.I., Sichinava L.G. et al. Obstetrics: textbook. Moscow: GEOTAR-Media, 2020. URL: https://www.geotar.ru/lots/NF0008921.html (in Russian).

58. Boggess KA, Lieff S, Murtha AP et al. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol 2003;101(2):227-31. DOI: 10.1016/s0029-7844(02)02314-1

59. Shetty M, Shetty PK, Ramesh A et al. Periodontal disease in pregnancy is a risk factor for preeclampsia. Acta Obstet Gynecol Scand 2010;89(5):718-21. DOI: 10.3109/00016341003623738

60. Politano GT, Passini R, Nomura ML et al. Correlation between periodontal disease, inflammatory alterations and pre-eclampsia. J Periodontal Res 2011;46(4):505-11. DOI: 10.1111/j.1600-0765.2011.01368.x

61. Moura da Silva G, Coutinho SB, Piscoya MD et al. Periodontitis as a risk factor for preeclampsia. J Periodontol 2012;83(11):1388-96. DOI: 10.1902/jop.2012.110256

62. Pattanashetti JI, Nagathan VM, Rao SM. Evaluation of Periodontitis as a Risk for Preterm Birth among Preeclamptic and Non-Preeclamptic Pregnant Women – A Case Control Study. J Clin Diagn Res 2013;7(8):1776-8. DOI: 10.7860/JCDR/2013/6497.3308

63. Ganesh PR, Mangaiyarkarasi M, Anagol R. Significant association between maternal periodontitis and pre-eclampsia complications – A retrospective case control study. J Indian Soc Periodontol 2025;29(2):123-9. DOI: 10.4103/jisp.jisp_85_24

64. Gatarayiha A, Ntaganira J, Brookes Z et al. Periodontitis and pre-eclampsia among pregnant women in Rwanda: A case-control study. PLoS One 2024;19(10):e0312103. DOI: 10.1371/journal.pone.0312103

65. Sayar F, Hoseini MS, Abbaspour S. Effect of periodontal disease on preeclampsia. Iran J Public Health 2011;40(3):122-7. URL: https://pubmed.ncbi.nlm.nih.gov/23113094/#full-view-affiliation-1

66. Contreras A, Herrera JA, Soto JE et al. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol 2006;77(2):182-8. DOI: 10.1902/jop.2006.050020

67. Herrera JA, Parra B, Herrera E et al. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. J Hypertens 2007;25(7):1459-64. DOI: 10.1097/HJH.0b013e3281139ea9

68. Ha JE, Oh KJ, Yang HJ et al. Oral health behaviors, periodontal disease, and pathogens in preeclampsia: a case-control study in Korea. J Periodontol 2011;82(12):1685-92. DOI: 10.1902/jop.2011.110035

69. Ha JE, Jun JK, Ko HJ et al. Association between periodontitis and preeclampsia in never-smokers: a prospective study. J Clin Periodontol 2014;41(9):869-74. DOI: 10.1111/jcpe.12281

70. Jaiman G, Nayak PA, Sharma S, Nagpal K. Maternal periodontal disease and preeclampsia in Jaipur population. J Indian Soc Periodontol 2018;22(1):50-4. DOI: 10.4103/jisp.jisp_363_15

71. Sgolastra F, Petrucci A, Severino M et al. Relationship between periodontitis and pre-eclampsia: a meta-analysis. PLoS One 2013;8(8):e71387. DOI: 10.1371/journal.pone.0071387

72. Wei BJ, Chen YJ, Yu L, Wu B. Periodontal disease and risk of preeclampsia: a meta-analysis of observational studies. PLoS One 2013;8(8):e70901. DOI: 10.1371/journal.pone.0070901

73. Huang X, Wang J, Liu J et al. Maternal periodontal disease and risk of preeclampsia: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci 2014;34(5):729-35. DOI: 10.1007/s11596-014-1343-8

74. Le QA, Akhter R, Coulton KM et al. Periodontitis and Preeclampsia in Pregnancy: A Systematic Review and Meta-Analysis. Matern Child Health J 2022;26(12):2419-43. DOI: 10.1007/s10995-022-03556-6

75. Karimi N, Samiee N, Moradi Y. The association between periodontal disease and risk of adverse maternal or neonatal outcomes: A systematic review and meta-analysis of analytical observational studies. Health Sci Rep 2023;6(10):e1630. DOI: 10.1002/hsr2.1630

76. Ansari Moghaddam S, Shayesteh S, Ranjbaran A. Evaluation the Risk of Preeclampsia in Periodontal Patients Compared With Healthy Individuals: A Meta-Analysis Study. Int J Dent 2025;2025:3360082. DOI: 10.1155/ijod/3360082

77. Daalderop LA, Wieland BV, Tomsin K et al. Periodontal Disease and Pregnancy Outcomes: Overview of Systematic Reviews. JDR Clin Trans Res 2018;3(1):10-27. DOI: 10.1177/2380084417731097

78. Трухан Д.И., Сулимов А.Ф., Трухан Л.Ю. Взаимосвязь преэклампсии и патологии пародонта. Клинический разбор в общей медицине. 2023;4(9):115-21. DOI: 10.47407/kr2023.4.9.00317

Trukhan D.I., Sulimov A.F., Trukhan L. Yu. The relationship between preeclampsia and periodontal pathology. Clinical review for general practice. 2023;4(9):115-21. DOI: 10.47407/kr2023.4.9.00317 (in Russian).

79. Mata K, Nobre AVV, Felix Silva PH et al. A new mixed model of periodontitis-induced preeclampsia: A pilot study. J Periodontal Res 2021;56(4):726-34. DOI: 10.1111/jre.12869

80. Tanneeru S, Mahendra J, Shaik MV. Evaluation of Microflora (Viral and Bacterial) in Subgingival and Placental Samples of Pregnant Women with Preeclampsia with and without Periodontal Disease: A Cross-Sectional Study. J Int Soc Prev Community Dent 2020;10(2):171-6. DOI: 10.4103/jispcd.JISPCD_341_19

81. Mahendra J, Mahendra L, Mugri MH et al. Role of Periodontal Bacteria, Viruses, and Placental mir155 in Chronic Periodontitis and Preeclampsia-A Genetic Microbiological Study. Curr Issues Mol Biol 2021;43(2):831-844. DOI: 10.3390/cimb43020060

82. Mahendra J, Mahendra L, Sharma V et al. Red-Complex Bacterial Levels in Pregnant Women With Preeclampsia and Chronic Periodontitis. Int Dent J 2022:S0020-6539(22)00229-5. DOI: 10.1016/j.identj.2022.10.003

83. Zhang W, Wu Q, Su J et al. Circulating miRNAs as Epigenetic Mediators of Periodontitis and Preeclampsia Association. Dis Markers 2022;2022:2771492. DOI: 10.1155/2022/2771492

84. Parthiban PS, Mahendra J, Logaranjani A et al. Association between specific periodontal pathogens, Toll-like receptor-4, and nuclear factor-κB expression in placental tissues of pre-eclamptic women with periodontitis. J Investig Clin Dent 2018;9(1). DOI: 10.1111/jicd.12265

85. Butera A, Maiorani C, Morandini A et al. Periodontitis in Pregnant Women: A Possible Link to Adverse Pregnancy Outcomes. Healthcare (Basel) 2023;11(10):1372. DOI: 10.3390/healthcare11101372

86. Wang Z, Cui L, Nan Y et al. Periodontitis & preeclampsia: were outer membrane vesicles a potential connection? J Matern Fetal Neonatal Med 2023;36(1):2183767. DOI: 10.1080/14767058.2023.2183767

87. Ruma M, Boggess K, Moss K et al. Maternal periodontal disease, systemic inflammation, and risk for preeclampsia. Am J Obstet Gynecol 2008;198(4):389.e1-5. DOI: 10.1016/j.ajog.2007.12.002

88. Chaparro A, Sanz A, Quintero A et al. Increased inflammatory biomarkers in early pregnancy is associated with the development of pre-eclampsia in patients with periodontitis: a case control study. J Periodontal Res 2013;48(3):302-7. DOI: 10.1111/jre.12008

89. Chaparro A, Gaedechens D, Ramírez V et al. Placental biomarkers and angiogenic factors in oral fluids of patients with preeclampsia. Prenat Diagn 2016;36(5):476-82. DOI: 10.1002/pd.4811

90. Chaparro A, Monckeberg M, Realini O et al. Gingival Crevicular Placental Alkaline Phosphatase Is an Early Pregnancy Biomarker for Pre-Eclampsia. Diagnostics (Basel) 2021;11(4):661. DOI: 10.3390/diagnostics11040661

91. Hauk V, D'Eramo L, Calo G et al. Gingival crevicular fluid from pregnant women impairs trophoblast cell function and trophoblast-neutrophil interaction. Am J Reprod Immunol 2022;88(2):e13558. DOI: 10.1111/aji.13558

92. Li Q, Ouyang X, Lin J. The impact of periodontitis on vascular endothelial dysfunction. Front Cell Infect Microbiol 2022;12:998313. DOI: 10.3389/fcimb.2022.998313

93. Yang SR, Ren XY. Research progress in association between endothelial dysfunction and periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi 2022;57(9):973-7. DOI: 10.3760/cma.j.cn112144-20220216-00064

94. Li X, Tse HF, Jin LJ. Novel endothelial biomarkers: implications for periodontal disease and CVD. J Dent Res 2011;90(9):1062-9. DOI: 10.1177/0022034510397194

95. Parenti A, Paccosi S, Cairo F, Defraia E. Treatment of Periodontitis for the Prevention of Endothelial Dysfunction: A Narrative Review. Curr Vasc Pharmacol 2015;13(6):749-58. DOI: 10.2174/1570161113666150818110653

96. Gurav AN. The implication of periodontitis in vascular endothelial dysfunction. Eur J Clin Invest 2014;44(10):1000-9. DOI: 10.1111/eci.12322.

97. Ruan F, Wang Y, Ying X et al. Bioinformatics analysis of shared biomarkers and immune pathways of preeclampsia and periodontitis. BMC Pregnancy Childbirth 2025;25(1):217. DOI: 10.1186/s12884-025-07277-w

98. Sanz M, Kornman K; Working group 3 of joint EFP/AAP workshop. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013;40(Suppl. 14):S164-9. DOI: 10.1111/jcpe.12083

99. Figuero E, Han YW, Furuichi Y. Periodontal diseases and adverse pregnancy outcomes: Mechanisms. Periodontol 2000 2020;83(1):175-88. DOI: 10.1111/prd.12295

100. Komine-Aizawa S, Aizawa S, Hayakawa S. Periodontal diseases and adverse pregnancy outcomes. J Obstet Gynaecol Res 2019;45(1):5-12. DOI: 10.1111/jog.13782

101. Saadaoui M, Singh P, Al Khodor S. Oral microbiome and pregnancy: A bidirectional relationship. J Reprod Immunol 2021;145:103293. DOI: 10.1016/j.jri.2021.103293

102. Sharma M, Sunda U, Dubey P, Tilva H. From Oral Health to Obstetric Outcomes: A Comprehensive Review of Periodontal Disease and Its Implications for Preeclampsia. Cureus 2024;16(6):e62995. DOI: 10.7759/cureus.62995

103. Рак молочной железы. Клинические рекомендации Минздрава России. М., 2021. URL: https://cr.minzdrav.gov.ru/preview-cr/379_4

Breast Cancer. Clinical Guidelines of the Ministry of Health of Russia. Moscow, 2021. URL: https://cr.minzdrav.gov.ru/preview-cr/379_4 (in Russian).

104. Aparna KS, Avinash BR, Gururaghavendran R. Association between periodontitis and breast cancer in Indian women – a pilot study in Dakshina Kannada, Karnataka. BMC Oral Health 2025;25(1):1521. DOI: 10.1186/s12903-025-06773-x

105. Nwizu NN, Marshall JR, Moysich K et al. Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. Cancer Epidemiol Biomarkers Prev 2017;26(8):1255-65. DOI: 10.1158/1055-9965.EPI-17-0212

106. Abolhasani-Zadeh F, Kheirandish A, Rajaeinia H, Hashemipour MA. Relationship between the risk of breast cancer and periodontal disease: a case-control study. Sci Rep 2025;15(1):10518. DOI: 10.1038/s41598-025-94710-x

107. Sun LM, Tsai FJ, Lin CL, Wu YH. Women with breast cancer exhibit a higher risk for periodontitis: A nationwide cohort study. J Dent Sci 2025;20(2):962-70. DOI: 10.1016/j.jds.2024.11.016

108. Romano F, Franco F, Mognetti B, Berta GN. Impact of Endocrine Therapy for Cancer on Periodontal Health: A Systematic Review. Cancers (Basel) 2025;17(18):3066. DOI: 10.3390/cancers17183066

109. Shao J, Wu L, Leng WD et al. Periodontal Disease and Breast Cancer: A Meta-Analysis of 1,73,162 Participants. Front Oncol 2018;8:601. DOI: 10.3389/fonc.2018.00601

110. Shi T, Min M, Sun C et al. Periodontal disease and susceptibility to breast cancer: A meta-analysis of observational studies. J Clin Periodontol 2018;45(9):1025-33. DOI: 10.1111/jcpe.12982

111. Wang K, Zhang Z, Wang Z. Assessment of the association between periodontal disease and total cancer incidence and mortality: a meta-analysis. Peer J 2022;10:e14320. DOI: 10.7717/peerj.14320.

112. Corbella S, Veronesi P, Galimberti V et al. Is periodontitis a risk indicator for cancer? A meta-analysis. PLoS One 2018;13(4):e0195683. DOI: 10.1371/journal.pone.0195683

113. Villar A, Mendes B, Viègas M et al. The relationship between periodontal disease and cancer: Insights from a Systematic Literature Network Analysis. Cancer Epidemiol 2024;91:102595. DOI: 10.1016/j.canep.2024.102595

114. Higham J, Scannapieco FA. Epidemiological associations between periodontitis and cancer. Periodontol 2000 2024;96(1):74-82. DOI: 10.1111/prd.12599

115. Issrani R, Reddy RJ, El-Metwally TH, Prabhu N. Periodontitis as a Risk Factor for Breast Cancer – What We Know Till Date? Asian Pac J Cancer Prev 2021;22(10):3109-14. DOI: 10.31557/APJCP.2021.22.10.3109

116. Gaba FI, González RC, Martïnez RG. The Role of Oral Fusobacterium nucleatum in Female Breast Cancer: A Systematic Review and Meta-Analysis. Int J Dent 2022;2022:1876275. DOI: 10.1155/2022/1876275

117. Stokowa-Sołtys K, Wojtkowiak K, Jagiełło K. Fusobacterium nucleatum – Friend or foe? J Inorg Biochem 2021;224:111586. DOI: 10.1016/j.jinorgbio.2021.111586

118. Ghosh A, Jaaback K, Boulton A et al. Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells 2024;13(8):717. DOI: 10.3390/cells13080717

119 .Guo X, Yu K, Huang R. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development. Mol Oral Microbiol 2024;39(1):1-11. DOI: 10.1111/omi.12446

120. Van der Merwe M, Van Niekerk G, Botha A, Engelbrecht AM. The onco-immunological implications of Fusobacterium nucleatum in breast cancer. Immunol Lett 2021;232:60-6. DOI: 10.1016/j.imlet.2021.02.007

121. Gu Y, Hou M, Chu J et al. The cause and effect of gut microbiota in development of inflammatory disorders of the breast. Eur J Med Res 2023;28(1):324. DOI: 10.1186/s40001-023-01281-6

122. Langel SN. mSphere of Influence: The maternal gut-mammary axis and its role in shaping neonatal health. mSphere 2025;10(3):e0055624. DOI: 10.1128/msphere.00556-24

123. Akbari E, Epstein JB, Samim F. Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers. Curr Oncol Rep 2024;26(11):1388-97. DOI: 10.1007/s11912-024-01591-w

124. Wu E, Liang J, Zhao J et al. Identification of potential shared gene signatures between periodontitis and breast cancer by integrating bulk RNA-seq and scRNA-seq data. Sci Rep 2025;15(1):11216. DOI: 10.1038/s41598-025-95703-6

125. Huang X, Zhuang Y, Wang R et al. Colonization by Porphyromonas gingivalis in cervical squamous cell carcinomas promotes metastasis through FimA/CD151/ITGB1 signaling. J Transl Med 2025;23(1):1166. DOI: 10.1186/s12967-025-06928-y